-
1
-
-
84879554009
-
Selected anti-tumor vaccines merit a place in multimodal tumor therapies
-
Weiss EM, Wunderlich R, Ebel N, Rubner Y, Schlucker E, Meyer-Pittroff R, Ott OJ, Fietkau R, Gaipl US, Frey B. Selected anti-tumor vaccines merit a place in multimodal tumor therapies. Frontiers in oncology. 2012; 2:132.
-
(2012)
Frontiers in oncology
, vol.2
, pp. 132
-
-
Weiss, E.M.1
Wunderlich, R.2
Ebel, N.3
Rubner, Y.4
Schlucker, E.5
Meyer-Pittroff, R.6
Ott, O.J.7
Fietkau, R.8
Gaipl, U.S.9
Frey, B.10
-
2
-
-
77952845427
-
4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines
-
Sharma RK, Schabowsky RH, Srivastava AK, Elpek KG, Madireddi S, Zhao H, Zhong Z, Miller RW, Macleod KJ, Yolcu ES, Shirwan H. 4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines. Cancer research. 2010; 70:3945-3954.
-
(2010)
Cancer research
, vol.70
, pp. 3945-3954
-
-
Sharma, R.K.1
Schabowsky, R.H.2
Srivastava, A.K.3
Elpek, K.G.4
Madireddi, S.5
Zhao, H.6
Zhong, Z.7
Miller, R.W.8
Macleod, K.J.9
Yolcu, E.S.10
Shirwan, H.11
-
3
-
-
79952184381
-
DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity
-
Lladser A, Mougiakakos D, Tufvesson H, Ligtenberg MA, Quest AF, Kiessling R, Ljungberg K. DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity. Molecular therapy: the journal of the American Society of Gene Therapy. 2011; 19:594-601.
-
(2011)
Molecular therapy: the journal of the American Society of Gene Therapy
, vol.19
, pp. 594-601
-
-
Lladser, A.1
Mougiakakos, D.2
Tufvesson, H.3
Ligtenberg, M.A.4
Quest, A.F.5
Kiessling, R.6
Ljungberg, K.7
-
5
-
-
84921908804
-
Tumor cell lysates as immunogenic sources for cancer vaccine design
-
Gonzalez FE, Gleisner A, Falcon-Beas F, Osorio F, Lopez MN, Salazar-Onfray F. Tumor cell lysates as immunogenic sources for cancer vaccine design. Human vaccines & immunotherapeutics. 2014; 10:3261-3269.
-
(2014)
Human vaccines & immunotherapeutics
, vol.10
, pp. 3261-3269
-
-
Gonzalez, F.E.1
Gleisner, A.2
Falcon-Beas, F.3
Osorio, F.4
Lopez, M.N.5
Salazar-Onfray, F.6
-
7
-
-
70350464351
-
Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis
-
Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, Kronenberg M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nature immunology. 2009; 10:1178-1184.
-
(2009)
Nature immunology
, vol.10
, pp. 1178-1184
-
-
Murai, M.1
Turovskaya, O.2
Kim, G.3
Madan, R.4
Karp, C.L.5
Cheroutre, H.6
Kronenberg, M.7
-
9
-
-
77954679956
-
Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy
-
Krummen M, Balkow S, Shen L, Heinz S, Loquai C, Probst HC, Grabbe S. Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy. Journal of leukocyte biology. 2010; 88:189-199.
-
(2010)
Journal of leukocyte biology
, vol.88
, pp. 189-199
-
-
Krummen, M.1
Balkow, S.2
Shen, L.3
Heinz, S.4
Loquai, C.5
Probst, H.C.6
Grabbe, S.7
-
10
-
-
84971012251
-
Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses
-
Abdul-Cader MS, Amarasinghe A, Abdul-Careem MF. Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses. Archives of virology. 2016.
-
(2016)
Archives of virology
-
-
Abdul-Cader, M.S.1
Amarasinghe, A.2
Abdul-Careem, M.F.3
-
11
-
-
38849095132
-
Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response
-
Plattner F, Yarovinsky F, Romero S, Didry D, Carlier MF, Sher A, Soldati-Favre D. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe. 2008; 3:77-87.
-
(2008)
Cell Host Microbe
, vol.3
, pp. 77-87
-
-
Plattner, F.1
Yarovinsky, F.2
Romero, S.3
Didry, D.4
Carlier, M.F.5
Sher, A.6
Soldati-Favre, D.7
-
12
-
-
84906935976
-
Toxoplasma gondii-derived profilin triggers human toll-like receptor 5-dependent cytokine production
-
Salazar Gonzalez RM, Shehata H, O'Connell MJ, Yang Y, Moreno-Fernandez ME, Chougnet CA, Aliberti J. Toxoplasma gondii-derived profilin triggers human toll-like receptor 5-dependent cytokine production. J Innate Immun. 2014; 6:685-694.
-
(2014)
J Innate Immun
, vol.6
, pp. 685-694
-
-
Salazar Gonzalez, R.M.1
Shehata, H.2
O'Connell, M.J.3
Yang, Y.4
Moreno-Fernandez, M.E.5
Chougnet, C.A.6
Aliberti, J.7
-
13
-
-
84872761427
-
Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii
-
Koblansky AA, Jankovic D, Oh H, Hieny S, Sungnak W, Mathur R, Hayden MS, Akira S, Sher A, Ghosh S. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity. 2013; 38:119-130.
-
(2013)
Immunity
, vol.38
, pp. 119-130
-
-
Koblansky, A.A.1
Jankovic, D.2
Oh, H.3
Hieny, S.4
Sungnak, W.5
Mathur, R.6
Hayden, M.S.7
Akira, S.8
Sher, A.9
Ghosh, S.10
-
14
-
-
85019440984
-
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
-
Toussi DN, Massari P. Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands. Vaccines (Basel). 2014; 2:323-353.
-
(2014)
Vaccines (Basel)
, vol.2
, pp. 323-353
-
-
Toussi, D.N.1
Massari, P.2
-
15
-
-
0037472447
-
Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically nontoxic double stranded RNA analogue poly [I]:poly [C(12) U] (Ampligen R)
-
Adams M, Navabi H, Jasani B, Man S, Fiander A, Evans AS, Donninger C, Mason M. Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically nontoxic double stranded RNA analogue poly [I]:poly [C(12) U] (Ampligen R). Vaccine. 2003; 21:787-790.
-
(2003)
Vaccine
, vol.21
, pp. 787-790
-
-
Adams, M.1
Navabi, H.2
Jasani, B.3
Man, S.4
Fiander, A.5
Evans, A.S.6
Donninger, C.7
Mason, M.8
-
16
-
-
57349153494
-
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)
-
Butowski N, Chang SM, Junck L, DeAngelis LM, Abrey L, Fink K, Cloughesy T, Lamborn KR, Salazar AM, Prados MD. A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05). J Neurooncol. 2009; 91:175-182.
-
(2009)
J Neurooncol
, vol.91
, pp. 175-182
-
-
Butowski, N.1
Chang, S.M.2
Junck, L.3
DeAngelis, L.M.4
Abrey, L.5
Fink, K.6
Cloughesy, T.7
Lamborn, K.R.8
Salazar, A.M.9
Prados, M.D.10
-
17
-
-
0022371997
-
Phase I trials of poly(I, C) complexes in advanced cancer
-
Krown SE, Kerr D, Stewart WE, 2nd, Field AK, Oettgen HF. Phase I trials of poly(I, C) complexes in advanced cancer. J Biol Response Mod. 1985; 4:640-649.
-
(1985)
J Biol Response Mod
, vol.4
, pp. 640-649
-
-
Krown, S.E.1
Kerr, D.2
Stewart, W.E.3
Field, A.K.4
Oettgen, H.F.5
-
18
-
-
70349328115
-
TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination
-
Pulko V, Liu X, Krco CJ, Harris KJ, Frigola X, Kwon ED, Dong H. TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination. J Immunol. 2009; 183:3634-3641.
-
(2009)
J Immunol
, vol.183
, pp. 3634-3641
-
-
Pulko, V.1
Liu, X.2
Krco, C.J.3
Harris, K.J.4
Frigola, X.5
Kwon, E.D.6
Dong, H.7
-
19
-
-
67049156789
-
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer
-
Feyerabend S, Stevanovic S, Gouttefangeas C, Wernet D, Hennenlotter J, Bedke J, Dietz K, Pascolo S, Kuczyk M, Rammensee HG, Stenzl A. Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer. Prostate. 2009; 69:917-927.
-
(2009)
Prostate
, vol.69
, pp. 917-927
-
-
Feyerabend, S.1
Stevanovic, S.2
Gouttefangeas, C.3
Wernet, D.4
Hennenlotter, J.5
Bedke, J.6
Dietz, K.7
Pascolo, S.8
Kuczyk, M.9
Rammensee, H.G.10
Stenzl, A.11
-
20
-
-
55249083982
-
Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma
-
Hofmann MA, Kors C, Audring H, Walden P, Sterry W, Trefzer U. Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma. J Immunother. 2008; 31:520-527.
-
(2008)
J Immunother
, vol.31
, pp. 520-527
-
-
Hofmann, M.A.1
Kors, C.2
Audring, H.3
Walden, P.4
Sterry, W.5
Trefzer, U.6
-
21
-
-
84880730418
-
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
-
Kruit WH, Suciu S, Dreno B, Mortier L, Robert C, Chiarion-Sileni V, Maio M, Testori A, Dorval T, Grob JJ, Becker JC, Spatz A, Eggermont AM, Louahed J, Lehmann FF, Brichard VG, et al. Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. J Clin Oncol. 2013; 31:2413-2420.
-
(2013)
J Clin Oncol
, vol.31
, pp. 2413-2420
-
-
Kruit, W.H.1
Suciu, S.2
Dreno, B.3
Mortier, L.4
Robert, C.5
Chiarion-Sileni, V.6
Maio, M.7
Testori, A.8
Dorval, T.9
Grob, J.J.10
Becker, J.C.11
Spatz, A.12
Eggermont, A.M.13
Louahed, J.14
Lehmann, F.F.15
Brichard, V.G.16
-
22
-
-
84878570297
-
Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours
-
Millward M, Underhill C, Lobb S, McBurnie J, Meech SJ, Gomez-Navarro J, Marshall MA, Huang B, Mather CB. Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours. Br J Cancer. 2013; 108:1998-2004.
-
(2013)
Br J Cancer
, vol.108
, pp. 1998-2004
-
-
Millward, M.1
Underhill, C.2
Lobb, S.3
McBurnie, J.4
Meech, S.J.5
Gomez-Navarro, J.6
Marshall, M.A.7
Huang, B.8
Mather, C.B.9
-
23
-
-
18944395052
-
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe
-
Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrandiz C, Garcia Diez A, Tebbs V, McRae S. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol. 2005; 152:939-947.
-
(2005)
Br J Dermatol
, vol.152
, pp. 939-947
-
-
Schulze, H.J.1
Cribier, B.2
Requena, L.3
Reifenberger, J.4
Ferrandiz, C.5
Garcia Diez, A.6
Tebbs, V.7
McRae, S.8
-
24
-
-
30644467155
-
Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2/neu-positive mammary carcinoma
-
Smorlesi A, Papalini F, Orlando F, Donnini A, Re F, Provinciali M. Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2/neu-positive mammary carcinoma. Gene Ther. 2005; 12:1324-1332.
-
(2005)
Gene Ther
, vol.12
, pp. 1324-1332
-
-
Smorlesi, A.1
Papalini, F.2
Orlando, F.3
Donnini, A.4
Re, F.5
Provinciali, M.6
-
25
-
-
77958051699
-
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients
-
Speiser DE, Schwarz K, Baumgaertner P, Manolova V, Devevre E, Sterry W, Walden P, Zippelius A, Conzett KB, Senti G, Voelter V, Cerottini JP, Guggisberg D, Willers J, Geldhof C, Romero P, et al. Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients. J Immunother. 2010; 33:848-858.
-
(2010)
J Immunother
, vol.33
, pp. 848-858
-
-
Speiser, D.E.1
Schwarz, K.2
Baumgaertner, P.3
Manolova, V.4
Devevre, E.5
Sterry, W.6
Walden, P.7
Zippelius, A.8
Conzett, K.B.9
Senti, G.10
Voelter, V.11
Cerottini, J.P.12
Guggisberg, D.13
Willers, J.14
Geldhof, C.15
Romero, P.16
-
26
-
-
79953759607
-
Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity
-
Jones RM, Sloane VM, Wu H, Luo L, Kumar A, Kumar MV, Gewirtz AT, Neish AS. Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity. Gut. 2011; 60:648-657.
-
(2011)
Gut
, vol.60
, pp. 648-657
-
-
Jones, R.M.1
Sloane, V.M.2
Wu, H.3
Luo, L.4
Kumar, A.5
Kumar, M.V.6
Gewirtz, A.T.7
Neish, A.S.8
-
27
-
-
84881558642
-
Flagellin enhances tumor-specific CD8(+) T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model
-
Nguyen CT, Hong SH, Sin JI, Vu HV, Jeong K, Cho KO, Uematsu S, Akira S, Lee SE, Rhee JH. Flagellin enhances tumor-specific CD8(+) T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model. Vaccine. 2013; 31:3879-3887.
-
(2013)
Vaccine
, vol.31
, pp. 3879-3887
-
-
Nguyen, C.T.1
Hong, S.H.2
Sin, J.I.3
Vu, H.V.4
Jeong, K.5
Cho, K.O.6
Uematsu, S.7
Akira, S.8
Lee, S.E.9
Rhee, J.H.10
-
28
-
-
0027939611
-
Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii
-
Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol. 1994; 153:2533-2543.
-
(1994)
J Immunol
, vol.153
, pp. 2533-2543
-
-
Gazzinelli, R.T.1
Wysocka, M.2
Hayashi, S.3
Denkers, E.Y.4
Hieny, S.5
Caspar, P.6
Trinchieri, G.7
Sher, A.8
-
29
-
-
77954439852
-
Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB/c mice
-
Pyo KH, Jung BK, Chai JY, Shin EH. Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB/c mice. Korean J Parasitol. 2010; 48:171-174.
-
(2010)
Korean J Parasitol
, vol.48
, pp. 171-174
-
-
Pyo, K.H.1
Jung, B.K.2
Chai, J.Y.3
Shin, E.H.4
-
30
-
-
84919778895
-
Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment
-
Pyo KH, Jung BK, Xin CF, Lee YW, Chai JY, Shin EH. Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment. Korean J Parasitol. 2014; 52:605-612.
-
(2014)
Korean J Parasitol
, vol.52
, pp. 605-612
-
-
Pyo, K.H.1
Jung, B.K.2
Xin, C.F.3
Lee, Y.W.4
Chai, J.Y.5
Shin, E.H.6
-
32
-
-
33947111517
-
Helper roles of NK, CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines
-
Kalinski P, Nakamura Y, Watchmaker P, Giermasz A, Muthuswamy R, Mailliard RB. Helper roles of NK, CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines. Immunologic research. 2006; 36:137-146.
-
(2006)
Immunologic research
, vol.36
, pp. 137-146
-
-
Kalinski, P.1
Nakamura, Y.2
Watchmaker, P.3
Giermasz, A.4
Muthuswamy, R.5
Mailliard, R.B.6
-
33
-
-
84893115383
-
Innate immunity to Toxoplasma gondii infection
-
Yarovinsky F. Innate immunity to Toxoplasma gondii infection. Nature reviews Immunology. 2014; 14:109-121.
-
(2014)
Nature reviews Immunology
, vol.14
, pp. 109-121
-
-
Yarovinsky, F.1
-
34
-
-
4444340034
-
An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth
-
Rankin EB, Yu D, Jiang J, Shen H, Pearce EJ, Goldschmidt MH, Levy DE, Golovkina TV, Hunter CA, Thomas-Tikhonenko A. An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth. Cancer Biol Ther. 2003; 2:687-693.
-
(2003)
Cancer Biol Ther
, vol.2
, pp. 687-693
-
-
Rankin, E.B.1
Yu, D.2
Jiang, J.3
Shen, H.4
Pearce, E.J.5
Goldschmidt, M.H.6
Levy, D.E.7
Golovkina, T.V.8
Hunter, C.A.9
Thomas-Tikhonenko, A.10
-
35
-
-
77957942243
-
Anticancer properties of the IL-12 family-focus on colorectal cancer
-
Engel MA, Neurath MF. Anticancer properties of the IL-12 family-focus on colorectal cancer. Curr Med Chem. 2010; 17:3303-3308.
-
(2010)
Curr Med Chem
, vol.17
, pp. 3303-3308
-
-
Engel, M.A.1
Neurath, M.F.2
-
36
-
-
66449088641
-
Pathogen recognition and inflammatory signaling in innate immune defenses
-
Table of Contents
-
Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009; 22:240-273, Table of Contents.
-
(2009)
Clin Microbiol Rev
, vol.22
, pp. 240-273
-
-
Mogensen, T.H.1
-
37
-
-
79958812738
-
Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants
-
Miyaji EN, Carvalho E, Oliveira ML, Raw I, Ho PL. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants. Braz J Med Biol Res. 2011; 44:500-513.
-
(2011)
Braz J Med Biol Res
, vol.44
, pp. 500-513
-
-
Miyaji, E.N.1
Carvalho, E.2
Oliveira, M.L.3
Raw, I.4
Ho, P.L.5
-
38
-
-
84921820958
-
Dendritic cell defects in the colorectal cancer
-
Legitimo A, Consolini R, Failli A, Orsini G, Spisni R. Dendritic cell defects in the colorectal cancer. Human vaccines & immunotherapeutics. 2014; 10:3224-3235.
-
(2014)
Human vaccines & immunotherapeutics
, vol.10
, pp. 3224-3235
-
-
Legitimo, A.1
Consolini, R.2
Failli, A.3
Orsini, G.4
Spisni, R.5
-
39
-
-
33750315676
-
Dynamic expression of chemokines and the infiltration of inflammatory cells in the HSV-infected cornea and its associated tissues
-
Araki-Sasaki K, Tanaka T, Ebisuno Y, Kanda H, Umemoto E, Hayashi K, Miyasaka M. Dynamic expression of chemokines and the infiltration of inflammatory cells in the HSV-infected cornea and its associated tissues. Ocular immunology and inflammation. 2006; 14:257-266.
-
(2006)
Ocular immunology and inflammation
, vol.14
, pp. 257-266
-
-
Araki-Sasaki, K.1
Tanaka, T.2
Ebisuno, Y.3
Kanda, H.4
Umemoto, E.5
Hayashi, K.6
Miyasaka, M.7
-
41
-
-
0036486763
-
Role of chemokines in the biology of natural killer cells
-
Robertson MJ. Role of chemokines in the biology of natural killer cells. Journal of leukocyte biology. 2002; 71:173-183.
-
(2002)
Journal of leukocyte biology
, vol.71
, pp. 173-183
-
-
Robertson, M.J.1
-
43
-
-
0033826812
-
Interferon-gamma and interleukin-12 pathway defects and human disease
-
Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev. 2000; 11:321-333.
-
(2000)
Cytokine Growth Factor Rev
, vol.11
, pp. 321-333
-
-
Dorman, S.E.1
Holland, S.M.2
-
44
-
-
80855156616
-
Resistance to Toxoplasma gondii infection in mice treated with silk protein by enhanced immune responses
-
Moon JH, Pyo KH, Jung BK, Chun HS, Chai JY, Shin EH. Resistance to Toxoplasma gondii infection in mice treated with silk protein by enhanced immune responses. The Korean journal of parasitology. 2011; 49:303-308.
-
(2011)
The Korean journal of parasitology
, vol.49
, pp. 303-308
-
-
Moon, J.H.1
Pyo, K.H.2
Jung, B.K.3
Chun, H.S.4
Chai, J.Y.5
Shin, E.H.6
|